Sources | Names Used |
---|---|
GDSC1000 | QL-VIII-58 |
PharmacoGx | QL-VIII-58 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RIPK3 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
mRNA | CCS | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |
mRNA | SCRN1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |
mRNA | IFI16 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
mRNA | USP28 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | KRT17 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | GC | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | MAD2L1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
mRNA | KRTAP6-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
mRNA | ZNF526 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.01 |